1 hr ago | Log Cabin Democrat
Kevin Griffin has joined Exchange Capital Corporation as Executive Vice President.
5 hrs ago | Sys-Con Media
Don't waste time trying to figure it out for yourself; tip the scales in your favor and add our experience to your team.
Corporations, rather than mafia bosses, have forked over what U.S. Department of Justice officials have described as some of the largest cases in U.S. history, based on data and documents from the fiscal year 2010-2012. In this photo, Stanford Financial Group's assets are pictured.
The global ion channel modulators market is forecast to reach a value of USD 21.4bn by end-2018, driven largely by deeper understanding of channelopathies and ongoing advances in electrophysiology, particularly automated electrophysiology.
Drug Giants Such as Bayer AG , Pfizer Inc. , and Roche Accused of Shady Soviet-Era Drug Trials Staying up-to-date has never been simpler.
Lpath, Inc. , the industry leader in bioactive lipid-targeted therapeutics,has initiated dosing in a Phase 2a single-arm trial where ASONEP is being investigated as a treatment for renal cell carcinoma in subjects that have failed the standard of care treatment with FDA-approved agents that block VEGF signaling /sunitinib maleate) and the mTOR ... (more)
May 23rd, 2013 - Markets received an early boost Wednesday after comments from Federal Reserve Chairman Ben Bernanke signaled that the central bank was not ready to ease up on economic stimulus.
's stock had its "hold" rating reaffirmed by research analysts at Independent Research GmbH in a report released on Thursday, Stock Ratings Network reports.
FiercePharma has some good figures to back up my posts the other day on R&D spending versus marketing .
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Two months after Pfizer announced the sale of its property at 5 Giralda Farms, the company says it's only moving across the corporate campus.
My last article concerning MannKind Corp. was a discussion of how its Afrezza will succeed where Pfizer's Exubera failed.
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.
** Oslo-listed oil services company Archer has agreed to sell its North American Rental and Tubular division to an affiliate of the Clearlake Capital Group for $244 million, it said on Wednesday.
Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news.
If you have been following the pharmaceutical industry lately, then you're probably no stranger to the "Patent Cliff" phenomenon that the industry is facing.
Drugmaker Pfizer Inc. plans to try to sell its controlling stake in its former animal health business, Zoetis Inc., through a voluntary stock exchange with Pfizer shareholders.